Latest News- Ophthalmology Therapeutics Market: Prescription drugs is expected to lead the Type segment during 2025-2029

The Ophthalmology Therapeutics Market is being driven by Increase in prevalence of eye diseases

The Ophthalmology Therapeutics Market is expected to grow at a CAGR of 7.4% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 25.3 billion. In the field of Ophthalmology, the administration of drugs to the eyes presents unique challenges due to various barriers that hinder the drug from effectively reaching the site of action. To address this issue, there has been a significant focus on the development of innovative therapeutics and delivery systems. These advancements aim to enhance drug bioavailability, minimize adverse effects, and extend the duration of drug action. Several novel ophthalmic delivery systems are being researched and developed, ensuring safety and reliability. These systems effectively bypass the eye's barriers, thereby improving the efficacy of treatments for various eye diseases. 

Get more information on Ophthalmology Therapeutics Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Type
  • Prescription drugs
  • OTC drugs
• Product
  • Retinal disorder therapeutics
  • Glaucoma therapeutics
  • Dry eye disease therapeutics
  • Eye infections and inflammation therapeutics
  • Others
• Drug Class
  • Anti-VEGF
  • Anti-inflammatory
  • Anti-glaucoma
  • Anti-infectives
  • Others
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
    • France
    • Italy
  • Asia
    • China
    • India
    • Japan
    • South Korea
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Increase in prevalence of eye diseases
• Approval of novel therapeutics and strong drug pipeline
• Strong uptake of anti-VEGF inhibitors

However, the market also witnesses some limitations, which are as follows:

• Expiry of patents of ophthalmology therapeutics
• High costs of treatment
• Side effects of current ophthalmology therapeutics

Benefits of Buying Global Ophthalmology Therapeutics Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Ophthalmology Therapeutics Market Research Report

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Ophthalmology Therapeutics Market encompasses various treatments and technologies for eye-related conditions. Key offerings include drug eluting implants, ophthalmic lasers, intravitreal injections, surgical instruments, visual impairment solutions, ocular prosthetics, eyelid surgery techniques, orbital surgery, ophthalmic imaging, and treatments for visual field defects, ocular oncology, conjunctivitis, keratitis, glaucoma, vitreoretinal surgery, ocular inflammation, neuro-ophthalmic diseases, corneal crosslinking, eyelid reconstruction, vision rehabilitation, diabetic retinopathy complications, macular degeneration, retinal vein occlusion, clinical trials, and ophthalmic devices for ocular allergy management.

Market Research Overview

The global ophthalmology therapeutics market encompasses entities involved in the research and development (R&D) or manufacturing of various eye care solutions, including intraocular pressure reduction treatments for glaucoma, age-related macular degeneration therapies, and diabetic retinopathy management options. According to Technavio, the pharmaceuticals sector within this market is anticipated to expand significantly due to demographic shifts, with the aging population in the US and Europe projected to reach over 60% by 2050 and 2030, respectively. This trend will fuel market growth, as the demand for treatments addressing age-related eye conditions and chronic diseases, such as glaucoma and diabetic retinopathy, escalates.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/